2023-508054-25-01已完成1 期
Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Nanexa AB
- 入组人数
- 12
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A phase I study to assess the pharmacokinetics of a single dose of a slow-release solid injection of EPT1647 in healthy male volunteers/AHealthy male volunteersOther -ACTRN12605000782639Epitan Limited6
招募中
不适用
A phase I study to evaluate the pharmacokinetic interactions and safety between Amlodipine/Valsartan combination tablet and Rosuvastatin in healthy adult volunteersDiseases of the circulatory systemKCT0001660Kyung Dong Pharmaceutical57
已完成
1 期
A Phase 1 Study of Olorofim in Healthy Japanese and Caucasian ParticipantsHealthy adult participantsJPRN-jRCT2031230016agata Tsutae24
招募中
1 期
MYCATJapanese Patients with Pulmonary MABC DiseaseJPRN-jRCT2031220211Ho Namkoong10
撤回
不适用
A Phase 1 Pharmacokinetic-Pharmacodynamic Study of Avelumab (MSB00100718C) in Patients with Previously Treated Advanced Stage Classical Hodgkin*s LymphomaHodgkin's Lymphomalymph node cancer10025319NL-OMON43446Pfizer15